Research Progress on the Mediating Role of Body Fat Percentage and Precision Prevention Strategies in Community Dietary Interventions for Geriatric Diabetes

Wenbo Luo

doi:10.54254/2753-8818/2026.ES36309

Article Information

Received: 27 July 2026

Published: 24 August 2026

DOI: https://doi.org/10.54254/2753-8818/2026.ES36309

Article Type: Research Article

Cite this article

Luo,W. (2026). Research Progress on the Mediating Role of Body Fat Percentage and Precision Prevention Strategies in Community Dietary Interventions for Geriatric Diabetes. Theoretical and Natural Science,188,1-8.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About this Volume

Volume Title: TNS Vol.188

Part of Series: Theoretical and Natural Science

ISSN: 2753-8818 (Print) / 2753-8826 (Online)

Copyright & License

[1]World Health Organization. (2020). Decade of healthy ageing: Baseline report. https://www.who.int/publications/i/item/9789240017900

[2]International Diabetes Federation. (2025). IDF diabetes atlas (11th ed.). https://www.diabetesatlas.org

[3]Wang, L., Peng, W., Zhao, Z., Zhang, M., Shi, Z., Song, Z., Zhang, X., Li, C., Huang, Z., Sun, X., Wang, L., Zhou, M., Wu, J., & Wang, Y. (2021). Prevalence and treatment of diabetes in China, 2013-2018.JAMA: The Journal of the American Medical Association, 326(24), 2498–2506. https://doi.org/10.1001/jama.2021.22208

[4]Gallagher, D., Heymsfield, S. B., Heo, M., Jebb, S. A., Murgatroyd, P. R., & Sakamoto, Y. (2000). Healthy percentage body fat ranges: An approach for developing guidelines based on body mass index.The American Journal of Clinical Nutrition, 72(3), 694–701. https://doi.org/10.1093/ajcn/72.3.694

[5]Hairi, N. N., Cumming, R. G., Naganathan, V., Handelsman, D. J., Le Couteur, D. G., Creasey, H., Waite, L. M., Seibel, M. J., & Sambrook, P. N. (2010). Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitation and physical disability: The concord health and ageing in men project.Journal of the American Geriatrics Society (JAGS), 58(11), 2055–2062. https://doi.org/10.1111/j.1532-5415.2010.03145.x

[6]Oliveros, E., Somers, V. K., Sochor, O., Goel, K., & Lopez-Jimenez, F. (2013). The concept of normal weight obesity.Progress in Cardiovascular Diseases, 56(4), 426–433. https://doi.org/10.1016/j.pcad.2013.10.003

[7]Donini, L. M., Busetto, L., Bauer, J. M., Bischoff, S., Boirie, Y., Cederholm, T., Cruz-Jentoft, A. J., Dicker, D., Frühbeck, G., Giustina, A., Gonzalez, M. C., Han, H.-S., Heymsfield, S. B., Higashiguchi, T., Laviano, A., Lenzi, A., Parrinello, E., Poggiogalle, E., Prado, C. M., … Barazzoni, R. (2020). Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review.Clinical Nutrition (Edinburgh, Scotland), 39(8), 2368–2388. https://doi.org/10.1016/j.clnu.2019.11.024

[8]Willett, W. (2013).Nutritional epidemiology (3rd ed.). Oxford University Press.

[9]Iacobucci, D. (2008).Mediation analysis. SAGE.

[10]Prado, C. M., Batsis, J. A., Donini, L. M., Gonzalez, M. C., & Siervo, M. (2024). Sarcopenic obesity in older adults: A clinical overview.Nature Reviews. Endocrinology, 20(5), 261–277. https://doi.org/10.1038/s41574-023-00943-z

[11]Ramirez, E., Salas, R., Bouzas, C., Pastor, R., & Tur, J. A. (2022). Comparison between original and reviewed consensus of European Working Group on Sarcopenia in Older People: A probabilistic cross-sectional survey among community-dwelling older people.Gerontology (Basel), 68(8), 869–876. https://doi.org/10.1159/000519304

[12]Baumgartner, R. N. (2000). Body composition in healthy aging.Annals of the New York Academy of Sciences, 904(1), 437–448. https://doi.org/10.1111/j.1749-6632.2000.tb06498.x

[13]Ruderman, N., Chisholm, D., Pi-Sunyer, X., & Schneider, S. (1998). The metabolically obese, normal-weight individual revisited.Diabetes, 47(5), 699–713. https://doi.org/10.2337/diabetes.47.5.699

[14]Reedy, J., Krebs-Smith, S. M., Miller, P. E., Liese, A. D., Kahle, L. L., Park, Y., & Subar, A. F. (2014). Higher diet quality is associated with decreased risk of all-cause, cardiovascular disease, and cancer mortality among older adults1, 2.The Journal of Nutrition, 144(6), 881.

[15]Salas-Salvadó, J., Bulló, M., Babio, N., Martínez-González, M. Á., Ibarrola-Jurado, N., Basora, J., Estruch, R., Covas, M. I., Corella, D., Arós, F., Ruiz-Gutiérrez, V., & Ros, E. (2011). Reduction in the incidence of type 2 diabetes with the Mediterranean diet: Results of the PREDIMED-Reus nutrition intervention randomized trial.Diabetes Care, 34(1), 14–19. https://doi.org/10.2337/dc10-1288

[16]Wolfe, R. R. (2006). Underappreciated role of muscle in health and disease.The American Journal of Clinical Nutrition, 84(3), 475–482. https://doi.org/10.1093/ajcn/84.3.475

[17]Paddon-Jones, D., & Rasmussen, B. B. (2009). Dietary protein recommendations and the prevention of sarcopenia.Current Opinion in Clinical Nutrition and Metabolic Care, 12(1), 86–90. https://doi.org/10.1097/MCO.0b013e32831cef8b

[18]Appel, L. J., Clark, J. M., Yeh, H.-C., Wang, N.-Y., Coughlin, J. W., Daumit, G., Miller, E. R., Dalcin, A., Jerome, G. J., Geller, S., Noronha, G., Pozefsky, T., Charleston, J., Reynolds, J. B., Durkin, N., Rubin, R. R., Louis, T. A., & Brancati, F. L. (2011). Comparative effectiveness of weight-loss interventions in clinical practice.The New England Journal of Medicine, 365(21), 1959–1968. https://doi.org/10.1056/NEJMoa1108660

[19]Villareal, D. T., Chode, S., Parimi, N., Sinacore, D. R., Hilton, T., Armamento-Villareal, R., Napoli, N., Qualls, C., & Shah, K. (2011). Weight loss, exercise, or both and physical function in obese older adults.The New England Journal of Medicine, 364(13), 1218–1229. https://doi.org/10.1056/NEJMoa1008234

[20]Sangwung, P., Petersen, K. F., Shulman, G., & Knowles, J. W. (2020). Mitochondrial dysfunction, insulin resistance, and potential genetic implications potential role of alterations in mitochondrial function in the pathogenesis of insulin resistance and type 2 diabetes.Endocrinology (Philadelphia), 161(4), Article 017. https://doi.org/10.1210/endocr/bqaa017

[21]Belfort, R., Mandarino, L., Kashyap, S., Wirfel, K., Pratipanawatr, T., Berria, R., DeFronzo, R. A., & Cusi, K. (2005). Dose-response effect of elevated plasma free fatty acid on insulin signaling.Diabetes (New York, N.Y.), 54(6), 1640–1648. https://doi.org/10.2337/diabetes.54.6.1640

[22]Kelley, D. E., Goodpaster, B., Wing, R. R., & Simoneau, J.-A. (1999). Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss.American Journal of Physiology: Endocrinology and Metabolism, 277(6), E1130–E1141. https://doi.org/10.1152/ajpendo.1999.277.6.E1130

[23]Challa, N. L., Sarkar, A., Kapettu, S., Phanithi, P. B., Chakrabarti, P., Parsa, K. V., & Misra, P. (2023). TGS1/PIMT regulates pro-inflammatory macrophage mediated paracrine insulin resistance: Crosstalk between macrophages and skeletal muscle cells.Biochimica Et Biophysica Acta (BBA) - Molecular Basis of Disease, 1870(1), 166878. https://doi.org/10.1016/j.bbadis.2023.166878

[24]Kauppinen, A., Suuronen, T., Ojala, J., Kaarniranta, K., & Salminen, A. (2013). Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.Cellular Signalling, 25(10), 1939–1948. https://doi.org/10.1016/j.cellsig.2013.06.007

[25]Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Reitman, M. L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., … Kadowaki, T. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.Nature Medicine, 7(8), 941–946. https://doi.org/10.1038/90984

[26]Kadowaki, T. (2006). Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.The Journal of Clinical Investigation, 116(7), 1784–1792. https://doi.org/10.1172/JCI29126

[27]Shepherd, P. R., & Kahn, B. B. (1999). Glucose transporters and insulin action — implications for insulin resistance and diabetes mellitus.The New England Journal of Medicine, 341(4), 248–257. https://doi.org/10.1056/NEJM199907223410406

[28]Witvrouw, E., Mahieu, N., Danneels, L., & McNair, P. (2004). Stretching and injury prevention: An obscure relationship.Sports Medicine (Auckland), 34(7), 443–449. https://doi.org/10.2165/00007256-200434070-00003

[29]DeFronzo, R. A., & Tripathy, D. (2009). Skeletal muscle insulin resistance is the primary defect in type 2 diabetes.Diabetes Care, 32(suppl 2), S157–S163. https://doi.org/10.2337/dc09-S302